Labena Ventures, the first ventures accelerator in Central and Eastern Europe focused on scaling innovations in the fields of medicine, biotechnology, food, and pharmaceuticals, has launched with access to funds worth over €100 million. It is the first and only accelerator of its kind in Central and Eastern European countries and is open to all start-ups, individuals, and universities with innovative solutions in 17 countries.
Labena Ventures is designed to leverage knowledge, connections, research and development infrastructure, and laboratories to help and empower all those who wish to apply, test, develop, commercialise, and scale their innovative solutions in the fields of biotechnology, medicine, pharmaceuticals and food industries, and environment. Labena Ventures accelerator is open to all start-ups, individuals, universities with innovative solutions in 17 countries.
Labena, which celebrates 30 years of business this year, started with the distribution and servicing of laboratory equipment. Today, they operate in the fields of laboratory and process analytics to support the pharmaceutical, food and medical industries. They also place a strong emphasis on research and development in pharmaceutical and bio-pharmaceutical, biotechnology, and diagnostics, working with major pharmaceutical companies and partners from around the world.
Since its foundation in 1993, the company has twice received the Slovenian Chamber of Commerce and Industry’s award for successful economic achievements, first in 2004 and again in 2018.
The accelerator will provide start-ups with access to over 100 excellent international mentors and state-of-the-art infrastructure and equipment, as well as connections with potential investors who together manage venture funds of more than €100 million.
The accelerator aims to help start-ups and innovative teams bring innovative solutions to end-users faster and more efficiently. The accelerator will provide access to its own know-how, the use of its own facilities, and available resources.
Dr. Dylan Attard, an aspiring entrepreneur and surgical trainee by background, is one of the chosen mentors for the Labena Ventures accelerator program. Dr. Attard has extensive experience in digital health, telemedicine, health policy, and the intersection of technology and healthcare. He has worked with a variety of organizations, including health systems, pharmaceutical companies, and start-ups.
As CEO of Med-Tech World Summit, Dr. Attard is passionate about promoting innovation in the healthcare industry and supporting the growth of start-ups in this field. He brings a wealth of knowledge and expertise to Labena Ventures, and is committed to helping entrepreneurs develop and scale their innovative solutions.
Anyone with an innovative project or solution in the fields of interest can apply to participate in the program from March 14th to May 15th, 2023, at www.labenaventures.com. From all applicants, up to 40 innovative teams will be selected by Labena Ventures expert committee and invited to attend a fully paid 3-day event of training sessions to upskill on business and presentation skills, as well as the skills to strategically position their idea or project in the marketplace.
The committee will then identify 10 most promising innovative teams to join the acceleration phase. Teams will be able to access support from over 100 international experts in the fields of entrepreneurship, finance, biotechnology, etc. and finally pitch to potential investors, including business angels, representatives of banks and funds.
Labena Ventures aims to create investable and scalable innovations and facilitate connection with pools of venture capital in Europe, US, and around the world. Labena has a wealth of experience and knowledge in this field and with the new platform aims to connect 17 markets and expand its business into new markets.
The chosen start-ups and mentors of the Labena Ventures accelerator program will have the opportunity to join the flagship Malta Med-Tech World Summit on 19-20th October, allowing them to showcase their innovations and connect with potential investors and partners during the conference.
In conclusion, the Labena Ventures accelerator is an exciting opportunity for start-ups and individuals in Central and Eastern Europe who have innovative solutions in the fields of medicine, biotechnology, food, and pharmaceuticals. With access to funds worth over €100 million, state-of-the-art infrastructure and equipment, and a network of international mentors and investors, Labena Ventures is well-positioned to help innovative teams bring their ideas to market and benefit humankind globally.
Join us in Malta for the Med-Tech World Summit on October 19-20, where we’ll bring together top minds in healthcare and technology to shape the future of medicine. Don’t miss this exciting opportunity.